SUBSCRIBE
SUBSCRIBE

Marketing

IN PARTNERSHIP WITH INTELLIA THERAPEUTICS
The commercial launch playbook: Team structure, readiness and execution
Intellia Therapeutics’s Senior Vice President Maria Natale discusses why the most successful launches are shaped long before approval, with strategy, structure and patient insight at the core.
June 15, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
PRESS RELEASES
Press Releases
Liraglutide Combination Products Incorporating Stevanato Group’s Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
July 30, 2026
 · 
6 min read
Press Releases
Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
July 30, 2026
 · 
7 min read
Press Releases
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
July 24, 2026
 · 
9 min read
Press Releases
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 23, 2026
 · 
6 min read
Press Releases
JCR Pharmaceuticals Receives Marketing Authorization in the United Arab Emirates for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
July 22, 2026
 · 
10 min read
Press Releases
Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
July 13, 2026
 · 
3 min read
Press Releases
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
July 13, 2026
 · 
4 min read
Press Releases
Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND
July 7, 2026
 · 
5 min read
Press Releases
Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom
June 29, 2026
 · 
12 min read
Press Releases
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
June 26, 2026
 · 
9 min read
Press Releases
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
June 23, 2026
 · 
9 min read